Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Phosphorylation Site Page:
Ser1108 - eIF4G (rat)

Site Information
GGSGAKPsDTASEAT    SwissProt Entrez-Gene
Predicted information: Scansite
Orthologous residues: eIF4G (human): S1106, eIF4G iso8 (human): S1107, eIF4G iso2 (mouse): S1096, eIF4G iso3 (human): S1066, eIF4G (rabbit): S909, eIF4G (mouse): S1110
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 3290600

In vivo Characterization
Methods used to characterize site in vivo: phospho-antibody (1, 2), western blotting (1)
Relevant cell line - cell type - tissue: 'muscle, skeletal' (1, 2)

Controlled by
Treatments: indinavir (2), insulin (2), leucine (1), sepsis (1)



Vary TC (2007) Acute oral leucine administration stimulates protein synthesis during chronic sepsis through enhanced association of eukaryotic initiation factor 4G with eukaryotic initiation factor 4E in rats. J Nutr 137, 2074-9
17709445   Curated Info


Hong-Brown LQ, et al. (2005) Indinavir alters regulators of protein anabolism and catabolism in skeletal muscle. Am J Physiol Endocrinol Metab 289, E382-90
15827064   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.